Literature DB >> 13922765

The effects of chlorpropamide on intermittent claudication and fibrinolysis.

M J TSAPOGAS, L T COTTON, P T FLUTE, J G MURRAY.   

Abstract

Entities:  

Keywords:  ANTIDIABETICS/therapy; FIBRINOLYSIS/pharmacology; INTERMITTENT CLAUDICATION/therapy

Mesh:

Substances:

Year:  1962        PMID: 13922765     DOI: 10.1016/s0140-6736(62)92255-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Response of fibrinolytic activity to venous occlusion.

Authors:  A G Shaper; N A Marsh; I Patel; F Kater
Journal:  Br Med J       Date:  1975-09-06

Review 2.  THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.

Authors:  J L STAFFORD
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

3.  THE ROLE OF FIBRINOLYSIS IN THE TREATMENT OF ARTERIAL THROMBOSIS: EXPERIMENTAL AND CLINICAL ASPECTS.

Authors:  M J TSAPOGAS
Journal:  Ann R Coll Surg Engl       Date:  1964-05       Impact factor: 1.891

4.  Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity.

Authors:  G R FEARNLEY; R CHAKRABARTI; P R AVIS
Journal:  Br Med J       Date:  1963-04-06

5.  Chlorpropamide and fibrinolytic activity in maturity onset diabetes mellitus.

Authors:  W D Alexander; R T Wensley; G Price; M Hartog
Journal:  Postgrad Med J       Date:  1976-05       Impact factor: 2.401

6.  Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage.

Authors:  H Fodstad
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1980
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.